Literature DB >> 11986564

Pharmacologic stress perfusion imaging with adenosine: role of simultaneous low-level treadmill exercise.

Habib Samady1, Frans J Th Wackers, Tammy M Joska, Barry L Zaret, Diwakar Jain.   

Abstract

BACKGROUND: Adenosine is commonly used for pharmacologic stress myocardial perfusion imaging (MPI). However, it frequently results in adverse effects, and the subdiaphragmatic tracer uptake may interfere with the image interpretation. Our aim was to determine the feasibility of combining low-level treadmill exercise with adenosine MPI and its impact on adverse effects, image quality, and myocardial ischemia. METHODS AND
RESULTS: Forty-one patients underwent technetium 99m sestamibi single photon emission computed tomography following adenosine and adenosine with low-level exercise (adenosine-Ex) on separate occasions and rest MPI. A comparison was made of symptoms, hemodynamic response, electrocardiographic changes, image quality, and image interpretation between the 2 protocols. With adenosine-Ex, fewer patients had one or more adverse effects (61% vs 90%; P =.006), more patients had ischemic electrocardiographic changes (34% vs 15%; P =.03), a higher percentage had excellent- or fair-quality images (88% vs 61%; P =.003), and they had higher heart-liver ratios (1.0 +/- 0.37 vs 0.84 +/- 0.29; P =.002) compared with adenosine alone. Four adenosine MPI studies, but only 2 adenosine-Ex studies, were uninterpretable because of excessive subdiaphragmatic radiotracer activity. Of the 39 patients with at least 1 interpretable stress study, interpretation was discordant in 11 (28%): 7 showed greater ischemia with adenosine-Ex, 2 uninterpretable adenosine studies were interpretable with adenosine-Ex, and 2 studies interpreted as abnormal with adenosine were normal by adenosine-Ex (both had normal coronary angiograms).
CONCLUSIONS: Simultaneous low-level treadmill exercise with adenosine Tc-99m sestamibi imaging is safe and feasible, significantly reduces unfavorable side effects, enhances image quality, and may result in greater ischemia detection compared with adenosine alone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11986564     DOI: 10.1067/mnc.2002.119973

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  36 in total

Review 1.  Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease.

Authors:  A S Iskandrian; M S Verani; J Heo
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

2.  Effect of maximal coronary vasodilation on transmural myocardial perfusion during tachycardia in the awake dog.

Authors:  R J Bache; F R Cobb
Journal:  Circ Res       Date:  1977-11       Impact factor: 17.367

3.  Dipyridamole and adenosine vasodilator stress for myocardial imaging: vive la différence!

Authors:  D D Miller; A J Labovitz
Journal:  J Am Coll Cardiol       Date:  1994-02       Impact factor: 24.094

4.  Thallium myocardial perfusion tomography using intravenous dipyridamole combined with maximal dynamic exercise.

Authors:  D J Pennell; S Mavrogeni; C Anagnostopoulos; P J Ell; S R Underwood
Journal:  Nucl Med Commun       Date:  1993-11       Impact factor: 1.690

5.  Impact of an abbreviated adenosine protocol incorporating adjunctive treadmill exercise on adverse effects and image quality in patients undergoing stress myocardial perfusion imaging.

Authors:  M D Elliott; T A Holly; S M Leonard; R C Hendel
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

6.  Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study.

Authors:  J Lette; J L Tatum; S Fraser; D D Miller; D D Waters; G Heller; E B Stanton; H S Bom; J Leppo; S Nattel
Journal:  J Nucl Cardiol       Date:  1995 Jan-Feb       Impact factor: 5.952

7.  Myocardial kinetics of Tc-MIBI in canine myocardium after dipyridamole.

Authors:  D K Glover; R D Okada
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

8.  Safety of intravenous dipyridamole thallium myocardial perfusion imaging: experience in 435 patients.

Authors:  S W Dubrey; J B Bomanji; M I Noble; R F Jewkes
Journal:  Nucl Med Commun       Date:  1993-04       Impact factor: 1.690

9.  Adenosine coronary vasodilation quantitative technetium 99m methoxy isobutyl isonitrile myocardial tomography in the identification and localization of coronary artery disease.

Authors:  E Nicolai; A Cuocolo; L Pace; A Nappi; P Sullo; S Cardei; L Argenziano; F Squame; P J Ell; M Salvatore
Journal:  J Nucl Cardiol       Date:  1996 Jan-Feb       Impact factor: 5.952

10.  Comparison of the myocardial uptake of a technetium-labeled isonitrile analogue and thallium.

Authors:  J A Leppo; D J Meerdink
Journal:  Circ Res       Date:  1989-09       Impact factor: 17.367

View more
  24 in total

1.  Prolonged myocardial stunning with adenosine infusion on gated SPECT imaging.

Authors:  Diwakar Jain
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

2.  A helping hand for regadenoson tests.

Authors:  Preeti Kansal; Thomas A Holly
Journal:  J Nucl Cardiol       Date:  2015-10-22       Impact factor: 5.952

3.  EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology.

Authors:  B Hesse; K Tägil; A Cuocolo; C Anagnostopoulos; M Bardiés; J Bax; F Bengel; E Busemann Sokole; G Davies; M Dondi; L Edenbrandt; P Franken; A Kjaer; J Knuuti; M Lassmann; M Ljungberg; C Marcassa; P Y Marie; F McKiddie; M O'Connor; E Prvulovich; R Underwood; B van Eck-Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

4.  Significance of ST depression during exercise treadmill stress and adenosine infusion myocardial perfusion imaging.

Authors:  Lok B Yap; Waleed Arshad; Ajay Jain; Arvinder S Kurbaan; Neil W Garvie
Journal:  Int J Cardiovasc Imaging       Date:  2005 Apr-Jun       Impact factor: 2.357

5.  Stress protocols and tracers.

Authors:  Milena J Henzlova; Manuel D Cerqueira; John J Mahmarian; Siu-Sun Yao
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

Review 6.  Pharmacologic stress myocardial perfusion imaging: a practical approach.

Authors:  Michael I Miyamoto; Sharon L Vernotico; Haresh Majmundar; Gregory S Thomas
Journal:  J Nucl Cardiol       Date:  2007-04       Impact factor: 5.952

7.  Symptom-limited exercise combined with dipyridamole stress: prognostic value in assessment of known or suspected coronary artery disease by use of gated SPECT imaging.

Authors:  Alan W Ahlberg; Sarkis B Baghdasarian; Haris Athar; Jeffrey P Thompsen; Deborah M Katten; Gavin L Noble; Igor Mamkin; Anuj R Shah; Ivette A Leka; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2008 Jan-Feb       Impact factor: 5.952

8.  Symptom-limited exercise during vasodilator stress: best of both worlds?

Authors:  Kevin A Bybee; Timothy M Bateman
Journal:  J Nucl Cardiol       Date:  2008 Jan-Feb       Impact factor: 5.952

Review 9.  The emerging role of the selective A2A agonist in pharmacologic stress testing.

Authors:  Anthony S Gemignani; Brian G Abbott
Journal:  J Nucl Cardiol       Date:  2010-06       Impact factor: 5.952

10.  Worsening of left ventricular ejection fraction induced by dipyridamole on Tl-201 gated myocardial perfusion imaging predicts significant coronary artery disease.

Authors:  Guang-Uei Hung; Kung-Wei Lee; Ching-Pei Chen; Kuang-Tao Yang; Wan-Yu Lin
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.